Mark Oehmigen1, Susanne Ziegler2, Bjoern W Jakoby3, Jens-Christoph Georgi4, Daniel H Paulus2, Harald H Quick5. 1. Institute of Medical Physics, University of Erlangen-Nuremberg, Erlangen, Germany Erwin L. Hahn Institute for Magnetic Resonance Imaging, University of Duisburg-Essen, Essen, Germany High Field and Hybrid MR Imaging, University Hospital Essen, Essen, Germany mark.oehmigen@uni-due.de. 2. Institute of Medical Physics, University of Erlangen-Nuremberg, Erlangen, Germany. 3. Siemens Healthcare Sector, Erlangen, Germany; and University of Surrey, Guildford, Surrey, United Kingdom. 4. Siemens Healthcare Sector, Erlangen, Germany; and. 5. Institute of Medical Physics, University of Erlangen-Nuremberg, Erlangen, Germany Erwin L. Hahn Institute for Magnetic Resonance Imaging, University of Duisburg-Essen, Essen, Germany High Field and Hybrid MR Imaging, University Hospital Essen, Essen, Germany.
Abstract
UNLABELLED: With the replacement of ionizing CT by MR imaging, integrated PET/MR in selected clinical applications may reduce the overall patient radiation dose when compared with PET/CT. Further potential for radiotracer dose reduction, while maintaining PET image quality (IQ) in integrated PET/MR, may be achieved by increasing the PET acquisition duration to match the longer time needed for MR data acquisition. To systematically verify this hypothesis under controlled conditions, this dose-reduction study was performed using a standardized phantom following the National Electrical Manufacturers Association (NEMA) IQ protocol. METHODS: All measurements were performed on an integrated PET/MR whole-body hybrid system. The NEMA IQ phantom was filled with water and a total activity of 50.35 MBq of (18)F-FDG. The sphere-to-background activity ratio was 8:1. Multiple PET data blocks of 20-min acquisition time were acquired in list-mode format and were started periodically at multiples of the (18)F-FDG half-lives. Different sinograms (2, 4, 8, and 16 min in duration) were reconstructed. Attenuation correction of the filled NEMA phantom was performed using a CT-based attenuation map template. The attenuation-corrected PET images were then quantitatively evaluated following the NEMA IQ protocol, investigating contrast recovery, background variability, and signal-to-noise ratio. Image groups with half the activity and twice the acquisition time were evaluated. For better statistics, the experiment was repeated 3 times. RESULTS: Contrast recovery, background variability, and signal-to-noise ratio remained almost constant over 3 half-life periods when the decreasing radiotracer activity (100%, 50%, 25%, and 12.5%) was compensated by increasing acquisition time (2, 4, 8, and 16 min). The variation of contrast recovery over 3 half-life periods was small (-6% to +7%), with a mean variation of 2%, compared with the reference setting (100%, 2 min). The signal-to-noise ratio of the hot spheres showed only minor variations over 3 half-life periods (5%). Image readers could not distinguish subjective IQ between the different PET acquisition setups. CONCLUSION: An approach to reduce the injected radiotracer activity in integrated PET/MR imaging, while maintaining PET IQ, was presented and verified under idealized experimental conditions. This experiment may serve as a basis for further clinical PET/MR studies using reduced radiotracer dose as compared with conventional PET/CT studies.
UNLABELLED: With the replacement of ionizing CT by MR imaging, integrated PET/MR in selected clinical applications may reduce the overall patient radiation dose when compared with PET/CT. Further potential for radiotracer dose reduction, while maintaining PET image quality (IQ) in integrated PET/MR, may be achieved by increasing the PET acquisition duration to match the longer time needed for MR data acquisition. To systematically verify this hypothesis under controlled conditions, this dose-reduction study was performed using a standardized phantom following the National Electrical Manufacturers Association (NEMA) IQ protocol. METHODS: All measurements were performed on an integrated PET/MR whole-body hybrid system. The NEMA IQ phantom was filled with water and a total activity of 50.35 MBq of (18)F-FDG. The sphere-to-background activity ratio was 8:1. Multiple PET data blocks of 20-min acquisition time were acquired in list-mode format and were started periodically at multiples of the (18)F-FDG half-lives. Different sinograms (2, 4, 8, and 16 min in duration) were reconstructed. Attenuation correction of the filled NEMA phantom was performed using a CT-based attenuation map template. The attenuation-corrected PET images were then quantitatively evaluated following the NEMA IQ protocol, investigating contrast recovery, background variability, and signal-to-noise ratio. Image groups with half the activity and twice the acquisition time were evaluated. For better statistics, the experiment was repeated 3 times. RESULTS: Contrast recovery, background variability, and signal-to-noise ratio remained almost constant over 3 half-life periods when the decreasing radiotracer activity (100%, 50%, 25%, and 12.5%) was compensated by increasing acquisition time (2, 4, 8, and 16 min). The variation of contrast recovery over 3 half-life periods was small (-6% to +7%), with a mean variation of 2%, compared with the reference setting (100%, 2 min). The signal-to-noise ratio of the hot spheres showed only minor variations over 3 half-life periods (5%). Image readers could not distinguish subjective IQ between the different PET acquisition setups. CONCLUSION: An approach to reduce the injected radiotracer activity in integrated PET/MR imaging, while maintaining PET IQ, was presented and verified under idealized experimental conditions. This experiment may serve as a basis for further clinical PET/MR studies using reduced radiotracer dose as compared with conventional PET/CT studies.
Authors: Mootaz Eldib; Jason Bini; Olivier Lairez; David D Faul; Niels Oesingmann; Zahi A Fayad; Venkatesh Mani Journal: Am J Nucl Med Mol Imaging Date: 2015-06-15
Authors: D L Bailey; B J Pichler; B Gückel; H Barthel; A J Beer; J Bremerich; J Czernin; A Drzezga; C Franzius; V Goh; M Hartenbach; H Iida; A Kjaer; C la Fougère; C N Ladefoged; I Law; K Nikolaou; H H Quick; O Sabri; J Schäfer; M Schäfers; H F Wehrl; T Beyer Journal: Mol Imaging Biol Date: 2015-10 Impact factor: 3.488
Authors: Ingo Einspieler; Klaus Thürmel; Thomas Pyka; Matthias Eiber; Sabine Wolfram; Philipp Moog; Christian Reeps; Markus Essler Journal: Eur J Nucl Med Mol Imaging Date: 2015-04-16 Impact factor: 9.236
Authors: Yan Wang; Luping Zhou; Biting Yu; Lei Wang; Chen Zu; David S Lalush; Weili Lin; Xi Wu; Jiliu Zhou; Dinggang Shen Journal: IEEE Trans Med Imaging Date: 2018-11-29 Impact factor: 10.048
Authors: Konstantinos G Zeimpekis; Felipe Barbosa; Martin Hüllner; Edwin ter Voert; Helen Davison; Patrick Veit-Haibach; Gaspar Delso Journal: Mol Imaging Biol Date: 2015-10 Impact factor: 3.488
Authors: Ferdinand Seith; Christina Schraml; Gerald Reischl; Konstantin Nikolaou; Christina Pfannenberg; Christian la Fougère; Nina Schwenzer Journal: Radiol Med Date: 2018-06-30 Impact factor: 3.469
Authors: Sergios Gatidis; Holger Schmidt; Christian la Fougère; Konstantin Nikolaou; Nina F Schwenzer; Jürgen F Schäfer Journal: Eur J Nucl Med Mol Imaging Date: 2016-08-26 Impact factor: 9.236
Authors: Benedikt Michael Schaarschmidt; Philipp Heusch; Christian Buchbender; Marcus Ruhlmann; Christoph Bergmann; Verena Ruhlmann; Marc Schlamann; Gerald Antoch; Michael Forsting; Axel Wetter Journal: Eur J Nucl Med Mol Imaging Date: 2015-08-06 Impact factor: 9.236